UNSPSC 85451502: The diagnosis of follow-up examination after radiapy for malignant neoplasm

In this classification, this covers the group of activities that yields a diagnosis of follow-up examination after radiotherapy for malignant neoplasm. Follow-up examination after radiotherapy for malignant neoplasm is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Z08.1.

UNSPSC 85451502, The diagnosis of follow-up examination after radiotherapy for malignant neoplasm, is a Commodity code with little recent state and local procurement activity directly aligned to its nominal scope. The three most recent opportunities posted under this code—a diagnostic imaging PACS implementation at San Mateo Medical Center, special education contracted services at Birdville Independent School District, and a temporary health professional staffing qualification vehicle at Santa Clara Health System—show a significant mismatch between the code's stated purpose (post-radiation oncology follow-up diagnostics) and the work actually being solicited. Only the San Mateo opportunity involves diagnostic imaging in any form, and it frames PACS as enterprise infrastructure for radiology, cardiology, and dental imaging across the full spectrum of clinical imaging rather than as post-treatment oncology surveillance. The other two solicitations are unrelated to diagnostic imaging or oncology follow-up entirely.

Activity under this code appears concentrated in California based on the three recent postings: San Mateo County Medical Center (October 2026 RFP due October 21, 2026) and Santa Clara Health System (October 7, 2026 deadline). No geographic spread to other states is evident in the recent-opportunities block. The absence of dedicated post-radiation follow-up imaging opportunities suggests either that state and local oncology programs are not actively procuring under this specific code, or that follow-up imaging services are being tagged at different UNSPSC classifications in practice. Business development professionals should verify whether this code is actively used in their target markets or whether oncology follow-up diagnostics are being sourced under adjacent radiology, imaging technology, or diagnostic services codes.